Abbasinejad, MD, evaluates each patients health history, weight-related concerns, current medications, and treatment goals before determining whether Ozempic may be appropriate
Weight loss often slows after the first several weeks as the body adapts to treatment and metabolic needs change
The fix is usually aggressive hydration and slower dose titration, not discontinuation
The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance
Negative impacts on energy or mood are uncommon
Sublingual delivery preserves italigning with evidence that glutathiones redox activity drives pigmentation balance, antioxidant defense, and tissue repair